Department of Surgery, Skåne University Hospital, Malmö, Sweden.
Department of Clinical Sciences, Lund University, Lund, Sweden.
Scand J Surg. 2024 Sep;113(3):202-210. doi: 10.1177/14574969241228411. Epub 2024 Feb 27.
Defunctioning loop ileostomy (DLI) is frequently used to decrease the consequences of anastomotic leak after ileal pouch-anal anastomosis (IPAA) surgery but is controversial because of stoma-associated morbidity. The aim of this study was to describe stoma-associated morbidity in IPAA-DLI patients compared with terminal ileostomy patients.
Patients treated with colectomy for inflammatory bowel disease at Skåne University Hospital, Sweden, between 2005 and 2021 were eligible for inclusion. Terminal stoma-related morbidity was measured until 12 months after colectomy, IPAA surgery, or conversion to ileorectal anastomosis, whichever occurred first. DLI-related morbidity was measured until 12 months after IPAA surgery or stoma closure, whichever occurred first. Laboratory data were reviewed up to 18 months after surgery since patients without complications were rarely subjected to blood sampling. Data on patient characteristics, renal function, surgical complications, and readmissions were collected retrospectively. Primary outcomes were DLI- and terminal ileostomy-related renal morbidity, whereas secondary outcomes focused on stoma-related complications.
The study cohort consisted of 165 patients with terminal ileostomy after colectomy (median (interquartile range (IQR)): stoma time 30 (15-74) months) and 42 patients with IPAA-DLI (median (IQR): stoma time 4 (3-5) months). One case of anastomotic IPAA leakage was observed. IPAA-DLI patients more often required hospital care due to high-volume stoma output immediately after surgery (0-30 days, 29%) compared with terminal ileostomy patients (4%, < 0.001). There were no significant differences in acute renal injury ( = 0.073) or chronic renal failure ( = 0.936) incidences between the groups. DLI closure was achieved in 95% of IPAA-DLI patients, with 5% suffering Clavien-Dindo complications > 2.
IPAA-DLI patients exhibited higher incidence of short-term high-volume stoma output without higher rates of acute renal injury or chronic renal failure compared with terminal ileostomy patients in this small single-center retrospective study suggesting that the risk of renal morbidity in IPAA-DLI patients may have been overestimated.
为了降低回肠贮袋肛管吻合术(IPAA)后吻合口漏的后果,常采用预防性回肠造口(DLI),但该术式仍存在争议,因为其与造口相关的发病率较高。本研究旨在比较预防性回肠造口(DLI)与末端回肠造口患者的造口相关发病率。
2005 年至 2021 年,在瑞典斯科讷大学医院接受结直肠切除术治疗炎症性肠病的患者符合入组条件。直至发生以下情况前,会对患者的末端造口相关发病率进行测量:结直肠切除术、IPAA 手术或改行回肠直肠吻合术。其中,以最早发生的事件为准。DLI 相关发病率的测量直至发生以下情况前:IPAA 手术或造口关闭,其中以最早发生的事件为准。术后 18 个月内会复查实验室数据,因为很少对无并发症的患者进行采血。回顾性收集患者特征、肾功能、手术并发症和再入院数据。主要结局为 DLI 和末端回肠造口相关的肾功能发病率,次要结局则侧重于造口相关并发症。
研究队列包括 165 例行结直肠切除术后行末端回肠造口术的患者(中位数(四分位距(IQR)):造口时间 30(15-74)个月)和 42 例行预防性回肠造口术(DLI)的患者(中位数(IQR):造口时间 4(3-5)个月)。观察到一例吻合口 IPAA 漏。与末端回肠造口术患者相比(4%, < 0.001),DLI 患者术后因高流量造口排泄物而更频繁地需要住院治疗(0-30 天,29%)。两组之间急性肾损伤( = 0.073)或慢性肾衰竭( = 0.936)的发生率无显著差异。95%的 DLI 患者成功关闭造口,5%的患者发生 Clavien-Dindo 并发症>2 级。
在本项小型单中心回顾性研究中,与末端回肠造口术患者相比,DLI 患者在短期内表现出更高的高流量造口排泄物发生率,但急性肾损伤或慢性肾衰竭的发生率并无升高,这表明 DLI 患者发生肾功能发病率的风险可能被高估。